C4 Therapeutics, Inc. (CCCC) — DEF 14A Filings
All DEF 14A filings from C4 Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
C4 Therapeutics Files DEF 14A on Executive Compensation
— Apr 29, 2025 Risk: low
C4 Therapeutics, Inc. filed a DEF 14A with the SEC on April 29, 2025, detailing executive compensation and corporate governance matters for the fiscal year endi -
C4 Therapeutics Files Definitive Proxy Statement
— Apr 29, 2024 Risk: low
C4 Therapeutics, Inc. (CCCC) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. C4 Therapeutics, Inc. filed a Definitive Proxy Statement (DEF 14A
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX